Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | KDM4A | O75164 | 1/20 | 0.30 |
| ▸ | FBP1 | P09467 | 1/20 | 0.30 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
| ▸ | F2 | P00734 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6941541 | 0.79 | L3MBTL1 (0.37) | L3MBTL1MEN1KMT2ATDP1KDM4A | |
| SCHEMBL6941543 | 0.79 | L3MBTL1 (0.37) | L3MBTL1MEN1KMT2ATDP1KDM4A | |
| SCHEMBL11793410 | 0.77 | F2 (0.40) | L3MBTL1MEN1KMT2ATDP1KDM4A | |
| SCHEMBL11793406 | 0.77 | F2 (0.40) | L3MBTL1MEN1KMT2ATDP1KDM4A | |
| SCHEMBL3311150 | 0.73 | L3MBTL1 (0.33) | L3MBTL1MEN1KMT2ATDP1KDM4A | |
| SCHEMBL3311147 | 0.73 | L3MBTL1 (0.33) | L3MBTL1MEN1KMT2ATDP1KDM4A | |
| SCHEMBL3307979 | 0.71 | F2 (0.36) | L3MBTL1MEN1KMT2ATDP1KDM4A | |
| SCHEMBL3307989 | 0.71 | F2 (0.36) | L3MBTL1MEN1KMT2ATDP1KDM4A | |
| SCHEMBL9484922 | 0.70 | ALDH1A1 (0.33) | — | |
| SCHEMBL9484926 | 0.70 | ALDH1A1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023104035-A1 | SUBSTITUTED MONOCYCLIC OR BICYCLIC HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | 英矽智能科技(上海)有限公司 | 2023-06-15 | — | — | WO | disclosed |